Home/Filings/4/0001493152-25-016349
4//SEC Filing

James Andrea S. 4

Accession 0001493152-25-016349

CIK 0001642380other

Filed

Sep 29, 8:00 PM ET

Accepted

Sep 30, 4:57 PM ET

Size

5.9 KB

Accession

0001493152-25-016349

Insider Transaction Report

Form 4
Period: 2025-09-28
James Andrea S.
Chief Financial Officer
Transactions
  • Award

    Option to Purchase Common Stock

    2025-09-28+235,000235,000 total
    Exercise: $3.33Exp: 2035-09-28Common Stock (235,000 underlying)
Footnotes (1)
  • [F1]33 and 1/3% of the options will become exercisable after one year of continuous service from the effective date of grant, and the balance will become exercisable in 24 equal monthly installments commencing one year after the date of grant subject to continuous service through the applicable vesting date.

Documents

1 file

Issuer

Insight Molecular Diagnostics Inc.

CIK 0001642380

Entity typeother

Related Parties

1
  • filerCIK 0002027010

Filing Metadata

Form type
4
Filed
Sep 29, 8:00 PM ET
Accepted
Sep 30, 4:57 PM ET
Size
5.9 KB